Print Page | Contact Us | Sign In | Join Now
News & Press: Current

Important information for APRN prescribers - Rescheduling ofHydrocodone Combination Products

Wednesday, October 8, 2014   (0 Comments)
Posted by: Lisa Presutti
 Important information for APRN prescribers -
Rescheduling of Hydrocodone Combination Products
 
The U.S. Drug Enforcement Agency (DEA) published in the Federal Register the final rule placing Hydrocodone (Trade Names: Vicodin®, Lortab®, Lorcet-HD®, Hycodan®, Vicoprofen®) into schedule II of the Federal Controlled Substances Act. The change was effective October 6, 2014. 
 
Additional information is available at the Board of Registration in Pharmacy web site at: http://www.mass.gov/eohhs/docs/dph/quality/boards/pharmacy/alerts/hydrocodone-rescheduling-cii.pdf